Lilly Endowment Inc.

In its 13F for Q2 2024 (holdings as of June 30, 2024, filed July 16, 2024), Lilly Endowment Inc. reported 1 stock position worth $88.2 billion. Its top holding was Eli Lilly (LLY) at 100.0% of the portfolio. Compared with Q1 2024, it reduced 1. The biggest sale was Eli Lilly (LLY, shares −2%).

Most Recent 13F
Q2 2026
Location
INDIANAPOLIS, IN
CIK
0000316011
Portfolio Value
$88.2B (Q2 2024)
SEC Filing
0001415889-24-019578 ↗ filed Jul 16, 2024

Holdings Value

0$50.0B$100.0B$150.0B Q1 2024: $76.9B Q1 2024 Q2 2024: $88.2B $88.2B Q2 2024 Q3 2024: $85.8B Q3 2024 Q4 2024: $74.8B Q4 2024 Q1 2025: $79.3B Q1 2025 Q2 2025: $74.8B Q2 2025 Q3 2025: $72.9B Q3 2025 Q4 2025: $99.1B Q4 2025 Q1 2026: $84.5B Q1 2026 Q2 2026: $108.4B Q2 2026

Holdings 1 stocks · $88.2B
LLY Eli Lilly & Co. 100.00% 97,367,369 $88.2B Reduce -1.6%

Portfolio Sells Q1 2024 → Q2 2024
LLY Eli Lilly & Co. Reduce -1.6% 100.00% 0.00

Portfolio Buys Q1 2024 → Q2 2024
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 1$108.4BLLY
Q1 2026 1$84.5BLLY
Q4 2025 1$99.1BLLY
Q3 2025 1$72.9BLLY
Q2 2025 1$74.8BLLY
Q1 2025 1$79.3BLLY
Q4 2024 1$74.8BLLY
Q3 2024 1$85.8BLLY
Q2 2024 1$88.2BLLY
Q1 2024 1$76.9BLLY